or Try an Advanced Search...

    Technical Analysis for ORGS - Orgenesis Inc.

    Grade Last Price % Change Price Change
    F 0.61 7.50% 0.04
    ORGS closed down 6.45 percent on Wednesday, May 15, 2024, on 8 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Flat Down Up
    Historical ORGS trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 7.50%
    MACD Bullish Centerline Cross Bullish 7.50%
    Upper Bollinger Band Walk Strength 7.50%
    Outside Day Range Expansion 7.50%
    Gapped Up Strength 7.50%
    Overbought Stochastic Strength 7.50%
    Upper Bollinger Band Touch Strength 7.50%
    200 DMA Resistance Bearish 0.56%
    Upper Bollinger Band Walk Strength 0.56%
    Weak + Overbought Other 0.56%
    Older End-of-Day Signals for ORGS ...

       Recent Intraday Alerts

    Alert Time
    Outside Day about 19 hours ago
    Down 3% about 19 hours ago
    Fell Below Previous Day's Low about 19 hours ago
    Rose Above Previous Day's High about 23 hours ago
    200 DMA Resistance about 23 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ORGS Chart by TradingView
    Basic chart:

    Profile

    Orgenesis Inc. Description

    Orgenesis Inc. is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company's subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced medicinal products. MaSTherCell is providing two types of services to its customers: process and assay development services and good manufacturing practice (GMP) contract manufacturing services. The CTB activity is based on its technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating (converting) them into pancreatic beta cell-like insulin producing cells for patients with Type I Diabetes. It intends to advance a product that combines cell-based therapy and regenerative medicine, Autologous Insulin Producing (AIP) cells, into clinical development.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Clinical Development Diabetes Stem Cell Cell Therapy Insulin Endocrine System Hormones Regenerative Medicine Contract Manufacturing Peptide Hormones Contract Manufacturing Services Type I Diabetes Assay Development Services Diabetes Mellitus Type 1 Medicinal Product Medicinal Products

    Is ORGS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 15 Orgenesis Provides Year End Business Update
    Apr 10 Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
    Apr 2 Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Mar 18 Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
    Mar 13 Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes
    Mar 4 Orgenesis announces $2.3M private placement
    Mar 4 Orgenesis Inc. Announces $2.3 Million Private Placement
    Feb 29 Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
    Feb 15 Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Feb 15 Dakota Gold And 2 Other Stocks Under $3 Insiders Are Buying
    See more ORGS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.49
    52 Week Low 0.25
    Average Volume 196,063
    200-Day Moving Average 0.61
    50-Day Moving Average 0.64
    20-Day Moving Average 0.53
    10-Day Moving Average 0.56
    Average True Range 0.06
    RSI (14) 51.46
    ADX 26.04
    +DI 24.96
    -DI 15.58
    Chandelier Exit (Long, 3 ATRs) 0.45
    Chandelier Exit (Short, 3 ATRs) 0.66
    Upper Bollinger Bands 0.60
    Lower Bollinger Band 0.47
    Percent B (%b) 0.76
    BandWidth 24.82
    MACD Line 0.00
    MACD Signal Line -0.01
    MACD Histogram 0.0139
    Fundamentals Value
    Market Cap 18.03 Million
    Num Shares 31.9 Million
    EPS -0.91
    Price-to-Earnings (P/E) Ratio -0.62
    Price-to-Sales 0.34
    Price-to-Book 0.77
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.68
    Resistance 3 (R3) 0.69 0.66 0.66
    Resistance 2 (R2) 0.66 0.63 0.66 0.66
    Resistance 1 (R1) 0.61 0.62 0.60 0.60 0.65
    Pivot Point 0.59 0.59 0.58 0.58 0.59
    Support 1 (S1) 0.54 0.56 0.52 0.53 0.48
    Support 2 (S2) 0.51 0.54 0.50 0.48
    Support 3 (S3) 0.46 0.51 0.47
    Support 4 (S4) 0.45